PUBLIC COMPANY
save$NUVLNuvalent, Inc.
$NUVL123.960.00%Cambridge, MA, USupdated 18d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2pre_registration
Upcoming
no upcoming catalysts on record
Recent(90d)
view all catalysts →Active trials
- phase3Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- —Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors
- phase1A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
- —Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors
- phase2A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- phase2A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 9, 26SELLPelish Henry E.· Chief Scientific Officer−$229K↗
- Apr 9, 26SELLPelish Henry E.· Chief Scientific Officer−$95K↗
- Apr 6, 26SELLPorter James Richard· President and CEO−$1.29M↗
- Apr 6, 26SELLPorter James Richard· President and CEO−$1.17M↗
- Apr 6, 26SELLPorter James Richard· President and CEO−$641K↗
- Apr 6, 26SELLPorter James Richard· President and CEO−$11K↗
- Apr 1, 26SELLBalcom Alexandra· Chief Financial Officer−$570K↗
- Apr 1, 26SELLBalcom Alexandra· Chief Financial Officer−$370K↗
- Apr 1, 26SELLBalcom Alexandra· Chief Financial Officer−$262K↗
- Mar 30, 26SELLNoci Darlene· Chief Development Officer−$291K↗
- Mar 30, 26SELLNoci Darlene· Chief Development Officer−$247K↗
- Mar 26, 26SELLMiller Deborah Ann· Chief Legal Officer−$279K↗
- Mar 26, 26SELLMiller Deborah Ann· Chief Legal Officer−$173K↗
- Mar 26, 26SELLMiller Deborah Ann· Chief Legal Officer−$92K↗
- Mar 25, 26SELLBalcom Alexandra· Chief Financial Officer−$1.37M↗
- Mar 24, 26SELLBalcom Alexandra· Chief Financial Officer−$735K↗
- Mar 24, 26SELLBalcom Alexandra· Chief Financial Officer−$247K↗
- Mar 24, 26SELLBalcom Alexandra· Chief Financial Officer−$112K↗
- Mar 13, 26SELLPelish Henry E.· Chief Scientific Officer−$257K↗
- Mar 13, 26SELLPelish Henry E.· Chief Scientific Officer−$170K↗
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that